Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 5—May 2005

Human T-cell Leukemia Virus Type 1 Molecular Variants, Vanuatu, Melanesia

Olivier Cassar*†, Corinne Capuano‡, Laurent Meertens†, Eliane Chungue*, and Antoine Gessain†Comments to Author 
Author affiliations: *Institut Pasteur de Nouvelle-Calédonie, Nouméa, France; †Institut Pasteur, Paris, France; ‡World Health Organization, Port-Vila, Vanuatu

Main Article

Table 1

Human T-cell leukemia virus type 1 (HTLV-1) antibody titers and molecular screening results for HTLV-1–seropositive women from Ambae Island, Vanuatu Archipelago*

Virus strain Age (y) PA titers IFA titers
WB pattern PCR
MT 2 C 19 3´ LTR 5´ LTR env
VAN 54 45 1/2,048 1/320 1/80 HTLV-I + + +
VAN 136 36 1/8,192 1/1,280 1/320 HTLV-I + + +
VAN 251 42 1/1,024 1/40 <1/20 HTLV-I + + +
VAN 335 42 1/4,096 1/1,280 1/160 HTLV-I + + +
DH1SIL2 (sister-in-law of VAN 335) 56 1/8,192 1/2,560 1/320 HTLV-I NA NA NA
AWM (mother of VAN 54) 63 1/1,024 1/160 1/40 HTLV-I NA NA NA

*PA, particle agglutination; IFA, immunofluorescence assay; WB, Western blot; PCR, polymerase chain reaction; LTR, long terminal repeat; NA, DNA not available.

Main Article

Page created: April 24, 2012
Page updated: April 24, 2012
Page reviewed: April 24, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.